Summary
The effects of selected vitamin D3 metabolites and analogs on bone collagen synthesis in vitro were examined in organ cultures of neonatal mouse calvarial bone. The incorporation of [3H]proline into the collagenase-digestible fraction of newly synthesized protein was progressively inhibited by 1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3) (10−12 M to 10−7 M) in 24-h cultures, and incorporation into noncollagen protein was also blunted at the higher doses employed. The synthetic analog 1α-hydroxyvitamin D3 (1α-OHD3) was almost 300-fold less potent an inhibitor of collagen synthesis than was 1α,25(OH)2D3, and the natural metabolites 25-hydroxyvitamin D3 (25OHD3) and 24R,25-dihydroxyvitamin D3 (24R,25(OH)2D3), 1000-fold less potent, although the dose-response curve for each of these compounds was not parallel with that for 1α,25(OH)2D3. The 24S,25(OH)2D3 enantiomer was four-fold less potent than 24R,25-(OH)2D3 or 25OHD3, and vitamin D3 showed less than 2% the activity of 25OHD3. The responses were unaffected by the substitution of 0.4% bovine albumin for 5% horse serum in the medium, and no stimulation of collagen synthesis was observed in response to 25-hydroxylated metabolites between 2×10−14 and 2×10−6 M or in cultures treated for up to 96 h with 24R,25(OH)2D3 (2×10−10M).
The overall results emphasize the similarity of the structural requirements for the inhibition of matrix synthesis and the stimulation of resorption by active vitamin D metabolites in bone. In addition, these studies support the importance of the 1-hydroxyl function to the biologic activity of vitamin D in the skeleton.
Similar content being viewed by others
References
Carlsson, A.: Tracer experiments on the effect of vitamin D on the skeletal metabolism of calcium and phosphate, Acta Physiol. Scand.26:212–220, 1952
Tanaka, Y., DeLuca, H. F.: Bone mineral mobilization activity of 1,25-dihydroxycholecalciferol, a metabolite of vitamin D, Arch. Biochem. Biophys.146:574–578, 1971
Holick, M. F., Garabedian, M., DeLuca, H. F.: 1,25-Dihydroxycholecalciferol: metabolite of vitamin D3 active on bone in anephric rats, Science176:1146–1147, 1972
Garabedian, M., Tanaka, M., Holick M. F., DeLuca, H. F.: Response of intestinal calcium transport and bone calcium mobilization to 1,25-dihydroxy-vitamin D3 in thyroparathyroidectomized rats, Endocrinology94:1022–1027, 1974
Thomassett, M., Redel, J., Marche, P., Cuisinier-Gleizes, P.: Duodenal calcium-binding protein (CaBP) and bone calcium mobilization in response to 24R,25-and 24S,25-dihydroxycholecalciferol in intact and nephrectomized rats, J. Steroid Biochem.9:159, 1978
Steenbock, H., Herting, D. C.: Vitamin D and growth, J. Nutr.57:449–468, 1955
Canas, F., Brand, J. S., Neuman, W. F., Terepka, A. R.: Some effects of vitamin D3 on collagen synthesis in rachitic chick cortical bone, Am. J. Physiol.216:1092–1096, 1969
Baylink, D., Stauffer, M., Wergedal, J., Rich, C.: Formation, mineralization and resorption of bone in vitamin D-deficient rats, J. Clin. Invest49:1122–1134, 1970
Tanaka, Y., DeLuca, H. F.: Role of 1,25-dihydroxyvitamin D3 in maintaining serum phosphorus and curing rickets, Proc. Natl. Acad. Sci. U.S.A.71:1040–1044, 1974
Russell, J. E., Avioli, L. V.: 25-Hydroxycholecalciferolenhanced bone maturation in the parathyroprivic state, J. Clin. Invest.56:792–798 1975
Raisz, L. G., Trummel, C. L., Holick, M. F., DeLuca, H. F.: 1,25-Dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture, Science175:768–769, 1972
Reynolds, J. J., Holick, M. F., DeLuca, H. F.: The role of vitamin D metabolites in bone resorption, Calcif. Tissue Int.12:295–301, 1973
Reynolds, J. J., Holick, M. F., DeLuca, H. F.: The effects of vitamin D analogues on bone resorption, Calcif. Tissue Int.15:333–339 1974
Stern, P. H., DeLuca, H. F., Ikekawa, N.: Bone resorbing activities of 24-hydroxy stereoisomers of 24-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3, Biochem. Biophys. Res. Commun.67:965–971, 1975
Stern, P. H., Trummel, C. L., Schnoes, H. K., DeLuca, H. F.: Bone resorbing activity of vitamin D metabolites and congenersin vitro: influence of hydroxyl substituents in the A ring. Endocrinology97:1552–1558, 1975
Stern, P. H., Mavreas, T., Trummel, C. L., Schnoes, H. K., DeLuca, H. F.: Bone-resorbing activity of analogues of 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol: effects of side chain modification and stereoisomerization on responses of fetal rat bonesin vitro, Mol. Pharmacol.12:879–886, 1976
Mahgoub, A., Sheppard, H.: Effect of hydroxy-vitamin D3 derivatives on45Ca release from rat fetal bonesin vitro, Endocrinology100:629–634 1977
Herrmann-Erlee, M. P. M., Gaillard, P. J.: The effects of 1,25-dihydroxycholecalciferol on embryonic bonein vitro: a biochemical and histological study, Calcif. Tissue Int.25:111–119, 1978
Wong, G. L., Luben, R. A., Cohn, D. V.: 1,25-Dihydroxycholecalciferol and parathormone: effects on isolated osteoclast-like and osteoblast-like cells, Science197:663–665 1977
Adams, J. S., Wong, G. L.: Lack of 24,25 dihydroxyvitamin D3 on isolated bone cells, Calcif. Tissue Int.28:172, 1979
Raisz, L. G., Maina, D. M., Gworek, S. C., Dietrich, J. W., Canalis, E. M.: Hormonal control of bone collagen synthesisin vitro: inhibitory effect of 1-hydroxylated vitamin D metabolites, Endocrinology102:731–735, 1978
Bordier, P., Rasmussen, H., Marie, P., Miravet, L., Gueris, J., Ryckwaert, A.: Vitamin D metabolites and bone mineralization in man, J. Clin. Endocrinol. Metab.46:284–294, 1978
Bordier, P., Zingraff, J., Gueris, J., Jungers, P., Marie, P., Pechet, M., Rasmussen, H.: The effect of 1α OH D3 and 1α,25(OH)2D3 on the bone in patients with renal osteodystrophy, Am J. Med.64:101, 1978
Kanis, J. A., Cundy, T., Bartlett, M., Smith, R., Heynen, G., Warner, G. T., Russell, R. G. G.: Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man? Br. Med. J.1:1382, 1978
Lieberherr, M., Pezant, E., Garabedian, M., Balsan, S.: Phosphatase content of rat calvaria afterin vitro administration of vitamin D3 metabolites, Calcif. Tissue Int.23:235–239, 1977
Corvol, M. T., Dumontier, M. F., Garabedian, M., Rappaport, R.: Vitamin D and cartilage. II. Biological activity of 25-hydroxycholecalciferol and 24,25-and 1,25-dihydroxycholecalciferols on cultured growth plate chondrocytes, Endocrinology102:1269–1274, 1978
Ornoy, A., Goodwin, D., Noff, D., Edelstein, S.: 24,25-Dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation, Nature276:517–519, 1978
Dziak, R.: Effects of vitamin D3 metabolites on bone cell calcium transport, Calcif. Tissue Int.26:65–70, 1978
Biggers, J. D., Gwatkin, R. B. L., Heyner, S.: Growth of embryonic avian and mammalian tibiae on a relatively simple chemically defined medium, Exp. Cell Res.25:41–58, 1961
Dietrich, J. W., Canalis, E. M., Maina, D. M., Raisz, L. G.: Hormonal control of bone collagen synthesisin vitro: effects of parathyroid hormone and calcitonin, Endocrinology98:943–949, 1976
Peterkofsky, B., Diegelmann, R.: Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins, Biochemistry10:988–993, 1971
Peterkofsky, B.: The effect of ascorbic acid on collagen polypeptide synthesis and proline hydroxylation during the growth of cultured fibroblasts, Arch. Biochem. Biophys.152:318, 1972
McArthur, J. W., Colton, T. (eds.): Statistics in Endocrinology. MIT Press, Cambridge, Mass., 1970
Taylor, C. M., Hann, J., St. John, J., Wallace, J. E., Mawer, E. B.: 1,25-Dihydroxycholecalciferol in human serum and its relationship with other metabolites of vitamin D3, Clin. Chim. Acta96:1–8, 1979
Belsey, R., DeLuca, H. F., Potts, J. T., Jr.: Competitive binding assay for vitamin D and 25-OH vitamin D, J. Clin. Endocrinol. Metab.33:554–557, 1971
Peck, W. A., Dowling, I.: Failure of 1,25-dihydroxycholecalciferol [1,25-(OH)2-D3] to modify cyclic AMP levels in parathyroid hormone-treated and untreated bone cells, Endocrine Res. Commun.3:157–166, 1976
Kream, B. E., Rowe, D. W., Gworek, S. C., Raisz, L. G.: Insulin and parathyroid hormone alter collagen-synthesis and procollagen messenger-RNA levels in fetal rat bone in vitro, Calcif. Tissue Int.28:148, 1979 (Abstr.)
Procsal, D. A., Okamura, W. H., Norman, A. W.: Structural requirements for the interaction of 1α,25-(OH)2-vitamin D3 with its chick intestinal receptor system, J. Biol. Chem.250:8382–8388, 1975
Kream, B. E., Jose, M., Yamada, S., DeLuca, H. F.: A specific high-affinity binding macromolecule for 1,25-dihydroxyvitamin D3 in fetal bone, Science197:1086–1088, 1977
Chen, T. L., Hirst, M. A., Feldman, D.: A receptor-like binding macromolecule for 1α,25-dihydroxycholecalciferol in cultured mouse bone cells, J. Biol. Chem.254:7491–7493, 1979
Cooke, N. E., Walgate, J., Haddad, J. G., Jr.: Human serum binding protein for vitamin D and its metabolites. II. Specific, high-affinity association with a protein in nucleated tissue, J. Biol. Chem.254:5965–5971, 1979
Canalis, E. M., Hintz, R. L., Dietrich, J. W., Maina, D. M., Raisz, L. G.: Effect of somatomedin and growth hormone on bone collagen synthesisin vitro, Metabolism26:1079–1087, 1977
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bringhurst, F.R., Potts, J.T. Effects of vitamin D metabolites and analogs on bone collagen synthesis in vitro. Calcif Tissue Int 34, 103–110 (1982). https://doi.org/10.1007/BF02411216
Issue Date:
DOI: https://doi.org/10.1007/BF02411216